Karyopharm Therapeutics reported $-49048000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 1342M 767M
Abbvie ABBV:US $ 4441M 338M
Acceleron Pharma XLRN:US $ -63.66M 0.06M
Amgen AMGN:US $ 828M 1301M
Astrazeneca AZN:US 1.13B 768M
AstraZeneca AZN:LN 1.13B 768M
Avrobio Inc AVRO:US -31375000 4.49M
Biocryst Pharmaceuticals BCRX:US $ -29.58M 21.8M
Bristol Myers Squibb BMY:US $ 1715M 36M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Enanta Pharmaceuticals ENTA:US $ -33.85M 4.15M
Epizyme EPZM:US $ -58231000 6.11M
GlaxoSmithKline GSK:LN 1.68B 18M
Johnson & Johnson JNJ:US $ 6662M 767M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Macrogenics MGNX:US $ -40279000 11.01M
Merk MRK:US $ 1497M 1517M
Mirati Therapeutics MRTX:US $ -164.19M 31.76M
Nektar Therapeutics NKTR:US $ -110.2M 0.81M
Novartis NVS:US $ 3479M 1064M
Novartis NOVN:VX 3.48B 1.06B
Pfizer PFE:US $ 5914M 397M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Tg Therapeutics TGTX:US $ -77.49M 11.71M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
Xencor XNCR:US $ 9.09M 24.76M
YTE INCY:US $ 140.84M 42.04M